no scripts enabled
Medikabazaar
Cart
Typbar 0.5ml Injection
Typbar 0.5ml Injection: Image 1
Typbar 0.5ml Injection: Image 2
Typbar 0.5ml Injection: Image 3

Your Advantages

Brand Bharat Biotech

Typbar 0.5ml Injection is a typhoid conjugate vaccine (TCV) designed for active immunization against typhoid fever caused by Salmonella typhi.

Each 0.5ml dose contains 25 µg of purified Vi-Capsular Polysaccharide from Salmonella typhi Ty2 strain, conjugated to Tetanus Toxoid. It is indicated for individuals aged 6 months to 45 years, including those traveling to high-risk areas.

The vaccine requires cold-chain storage at +2°C to +8°C and must not be frozen. Typbar 0.5ml Injection is manufactured by Bharat Biotech and was prequalified by the World Health Organization (WHO) in January 2018.

Key Features : 

Antigen Composition: Contains 25 µg of purified Vi-Capsular Polysaccharide of Salmonella typhi Ty2 conjugated to Tetanus Toxoid per 0.5ml dose.
Approved Indications: Provides active immunization against Salmonella typhi infection for individuals from 6 months to 45 years of age.
Cold-chain Storage: Requires storage at +2°C to +8°C and must not be frozen.
Regulatory Approval: Manufactured by Bharat Biotech and prequalified by the World Health Organization (WHO) in January 2018.

Antigen CompositionPurified Vi-Capsular Polysaccharide of S. typhi Ty2 conjugated to Tetanus Toxoid, 25 µg
Approved IndicationsActive immunization against Salmonella typhi infection for individuals aged 6 months to 45 years
Cold-chain Storage Temperature+2°C to +8°C
Regulatory ApprovalWHO Prequalified (January 2018), Manufactured by Bharat Biotech
Route of AdministrationIntramuscular
twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited